DK200289A - Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat - Google Patents

Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat Download PDF

Info

Publication number
DK200289A
DK200289A DK200289A DK200289A DK200289A DK 200289 A DK200289 A DK 200289A DK 200289 A DK200289 A DK 200289A DK 200289 A DK200289 A DK 200289A DK 200289 A DK200289 A DK 200289A
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical
acid derivative
suitable salt
immunosuppressive effective
Prior art date
Application number
DK200289A
Other languages
English (en)
Other versions
DK170414B1 (da
DK200289D0 (da
Inventor
Neil Richard Ackerman
Bruce Donald Jaffee
Scott Edward Loveless
Russell Howard Neubauer
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK200289D0 publication Critical patent/DK200289D0/da
Publication of DK200289A publication Critical patent/DK200289A/da
Application granted granted Critical
Publication of DK170414B1 publication Critical patent/DK170414B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transplantation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK200289A 1988-04-26 1989-04-25 Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater DK170414B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18624388 1988-04-26
US07/186,243 US4968701A (en) 1988-04-26 1988-04-26 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents

Publications (3)

Publication Number Publication Date
DK200289D0 DK200289D0 (da) 1989-04-25
DK200289A true DK200289A (da) 1989-10-27
DK170414B1 DK170414B1 (da) 1995-08-28

Family

ID=22684181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200289A DK170414B1 (da) 1988-04-26 1989-04-25 Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater

Country Status (13)

Country Link
US (1) US4968701A (da)
EP (1) EP0339485B1 (da)
JP (1) JP2650757B2 (da)
KR (1) KR0134376B1 (da)
AT (1) ATE87480T1 (da)
CA (1) CA1333155C (da)
DE (1) DE68905642T2 (da)
DK (1) DK170414B1 (da)
IE (1) IE64760B1 (da)
IL (1) IL90055A (da)
MY (1) MY106038A (da)
PT (1) PT90363B (da)
ZA (1) ZA893087B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202005021811U1 (de) 2004-09-27 2010-04-15 Novozymes A/S Körnchen mit einem Kern und einer Beschichtung

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
US6004979A (en) * 1991-02-07 1999-12-21 Hoechst Marion Roussel Nitrogenous bicycles
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
EP0830133A1 (en) * 1995-04-28 1998-03-25 Takeda Chemical Industries, Ltd. Therapeutic composition for arthritis
WO1997042953A1 (en) * 1996-05-10 1997-11-20 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
ES2173391T3 (es) * 1996-08-16 2002-10-16 Pfizer Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
EP0991623A2 (en) 1997-06-19 2000-04-12 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2108099A (en) * 1998-01-30 1999-08-16 Procept, Inc. Immunosuppressive agents
MX2016006678A (es) 2013-11-22 2016-09-13 Genzyme Corp Nuevos metodos para tratar enfermedades neurodegenerativas.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6592M (da) * 1967-10-31 1968-12-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CH576447A5 (da) * 1972-03-10 1976-06-15 Ciba Geigy Ag
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202005021811U1 (de) 2004-09-27 2010-04-15 Novozymes A/S Körnchen mit einem Kern und einer Beschichtung
DE202005021810U1 (de) 2004-09-27 2010-04-22 Novozymes A/S Körnchen mit einem Kern und einer Beschichtung

Also Published As

Publication number Publication date
IE891328L (en) 1989-10-26
AU3332189A (en) 1989-11-02
DE68905642D1 (de) 1993-05-06
MY106038A (en) 1994-03-31
US4968701A (en) 1990-11-06
DE68905642T2 (de) 1993-08-12
IL90055A0 (en) 1989-12-15
IE64760B1 (en) 1995-09-06
PT90363A (pt) 1989-11-10
DK170414B1 (da) 1995-08-28
ZA893087B (en) 1990-12-28
DK200289D0 (da) 1989-04-25
JP2650757B2 (ja) 1997-09-03
KR0134376B1 (ko) 1998-04-21
CA1333155C (en) 1994-11-22
EP0339485B1 (en) 1993-03-31
IL90055A (en) 1993-05-13
KR900016137A (ko) 1990-11-12
EP0339485A1 (en) 1989-11-02
PT90363B (pt) 1994-08-31
ATE87480T1 (de) 1993-04-15
AU628045B2 (en) 1992-09-10
JPH01313428A (ja) 1989-12-18

Similar Documents

Publication Publication Date Title
DK200289D0 (da) Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat
FI883249A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
DK653688A (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
PT87474A (pt) Process for the preparation of pharmaceutical compounds which contain ester 1-acetoxi-ethylic of cefuroxime
DK39082A (da) Aromatiske heterocycliske estre af steroider,fremgangsmaade til deres fremstilling samt deres anvendelse
NO900306D0 (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
SE7903186L (sv) Cerebralverksamt medel
NO883506L (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
DK199789A (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
NO883074L (no) Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater.
FI913131A (fi) Nya 3,3'-ditiobis (propionsyror)och deras estrar.
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
ITMI920539A0 (it) Procedimento per la separazione dell'acido ftalimmido perossicaproico da soluzioni di solventi organici
FI880385A0 (fi) Substituerade 3-fenyl-7h-tiazolo /3,2-b//1,2,4/-triazin-7-oner, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning, samt naogra vid framstaellningen av naemnda foereningar bildade mellanprodukter.
PT87743A (pt) Process for the preparation of pyrimidine derivatives and of insecticide and acaricide compounds which contain them
DK163432C (da) Analogifremgangsmaade til fremstilling af oe1,2,4aatriazolo-oe4,3-aaaquinoxalin-4-amin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
IT8521824A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l.-aspartil-l-fenilalanina apartire da anidride n-fenacetil-l-aspartica edl-fenilalanina metil estere.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed